EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische Studie

Effect of different frequencies of intermittently scanned continuous glucose monitoring on glycemic control in adults with type 2 diabetes not using insulin: The COMPASS-libre randomized controlled trial

Hiroshi Okada, Shota Suzuki, Masayuki Domichi, Naoki Sakane

Research in Social and Administrative Pharmacy · 2026-08 · 22 (8) · 819-825

DOI: 10.1016/j.sapharm.2026.04.005 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Research in Social and Administrative Pharmacy, 2026-08. Verfasst von Hiroshi Okada und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Social & Community Pharmacy, School of Pharmaceutical Sciences, Wakayama Medical University, Wakayama, Japan; Department of Preventive …. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Continuous Glucose Monitoring, Glycemic Control, Blood Glucose. Die Arbeit nennt 23 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND AND OBJECTIVE: Intermittently scanned continuous glucose monitoring (isCGM) has been shown to improve glycemic control in individuals with type 2 diabetes mellitus (T2DM), yet the optimal frequency of CGM use remains unclear, particularly in community pharmacy settings. This study evaluated the effects of different frequencies of isCGM use within a brief pharmacist-led educational program for adults with T2DM treated without insulin. METHODS: The COMPASS-Libre study was a multicenter, open-label randomized controlled trial conducted in community pharmacies in Japan. Adults with T2DM and glycated hemoglobin (HbA1c) ≥7% were randomized (1:1) to either a single-CGM group (one sensor) or a multiple-CGM group (four sensors) over 12 weeks. The primary outcome was change in time in range (TIR; glucose 70-180 mg/dL). Secondary outcomes included time above range (TAR), time below range (TBR), glucose management indicator (GMI), and coefficient of variation (%CV), along with behavioral and patient-reported outcomes. RESULTS: Seventy-seven participants were randomized (mean age 60.9 ± 10.4 years; mean HbA1c 7.4 ± 0.8%), with a dropout rate of 16.8%. TIR significantly improved in both the single-CGM group (64.6 ± 23.0% to 71.1 ± 17.9%, P = 0.0496) and the multiple-CGM group (62.5 ± 20.8% to 69.6 ± 21.7%, P = 0.002), with no significant between-group difference in change (6.4 ± 17.1% vs 7.3 ± 12.0%, P = 0.808). TAR decreased significantly in both groups, while TBR remained low and unchanged. GMI also improved in both groups, with no significant between-group differences. Improvements in dietary behavior were observed only in the multiple-CGM group (P = 0.032). CONCLUSIONS: A brief pharmacist-led educational program using intermittently scanned CGM improved glycemic metrics in adults with non-insulin-treated T2DM. However, increasing the frequency of CGM use did not provide additional glycemic benefit compared with a single CGM exposure. These findings suggest that even limited CGM use may support behavioral change and glycemic improvement in community pharmacy settings. TRIAL REGISTRATION: UMIN000048893.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Continuous Glucose MonitoringGlycemic ControlBlood GlucoseHumansFemaleMiddle AgedMaleGlycated HemoglobinAgedJapanCommunity Pharmacy ServicesPatient Education as TopicBlood Glucose Self-MonitoringPharmacistsInsulin

Stichwörter der Autor:innen

Continuous glucose monitoringFoodNutritionSelf-careType 2 diabetes

Substanzen

Glycated HemoglobinBlood GlucoseInsulin

Autor:innen und Institutionen

  • Department of Social & Community Pharmacy, School of Pharmaceutical Sciences, Wakayama Medical University, Wakayama, Japan; Department of Preventive Services, Kyoto University School of Public Health, Kyoto, Japan.
  • Department of Social & Community Pharmacy, School of Pharmaceutical Sciences, Wakayama Medical University, Wakayama, Japan; Institute for Clinical and Translational Science, Nara Medical University Hospital, Nara, Japan.
  • Division of Preventive Medicine, Clinical Research Institute, National Hospital Organization Kyoto Medical Center, Kyoto, Japan.
  • Division of Preventive Medicine, Clinical Research Institute, National Hospital Organization Kyoto Medical Center, Kyoto, Japan. Electronic address: nsakane@gf6.so-net.ne.jp.

Zitieren

APA

Okada, H., Suzuki, S., Domichi, M., & Sakane, N. (2026). Effect of different frequencies of intermittently scanned continuous glucose monitoring on glycemic control in adults with type 2 diabetes not using insulin: The COMPASS-libre randomized controlled trial. Research in Social and Administrative Pharmacy, 22(8), 819-825. https://doi.org/10.1016/j.sapharm.2026.04.005

Vancouver

Okada H, Suzuki S, Domichi M, Sakane N. Effect of different frequencies of intermittently scanned continuous glucose monitoring on glycemic control in adults with type 2 diabetes not using insulin: The COMPASS-libre randomized controlled trial. Research in Social and Administrative Pharmacy. 2026;22(8):819-825. doi:10.1016/j.sapharm.2026.04.005

BibTeX
@article{Okada2026,
  author = {Okada, Hiroshi and Suzuki, Shota and Domichi, Masayuki and Sakane, Naoki},
  title = {Effect of different frequencies of intermittently scanned continuous glucose monitoring on glycemic control in adults with type 2 diabetes not using insulin: The COMPASS-libre randomized controlled trial},
  journal = {Research in Social and Administrative Pharmacy},
  year = {2026},
  volume = {22},
  number = {8},
  pages = {819--825},
  doi = {10.1016/j.sapharm.2026.04.005}
}
Kostenlos starten →